Literature DB >> 11990245

A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

M Lloyd Jones1, S Hummel, N Bansback, B Orr, M Seymour.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11990245

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  5 in total

Review 1.  Ethical issues in newborn screening and the impact of new technologies.

Authors:  Bridget Wilcken
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

2.  Chemotherapy of Metastatic Colorectal Cancer.

Authors:  Everardo D Saad; Paulo M Hoff
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

Review 3.  Cost considerations in the treatment of colorectal cancer.

Authors:  Frank G A Jansman; Maarten J Postma; Jacobus R B J Brouwers
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 4.  The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.

Authors:  S E Ward; E Kaltenthaler; J Cowan; M Marples; B Orr; M T Seymour
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

5.  Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy.

Authors:  Shuichi Yajima; Hisanori Shimizu; Hiroyuki Sakamaki; Shunya Ikeda; Naoki Ikegami; Jun-Ichiro Murayama
Journal:  BMC Health Serv Res       Date:  2016-01-04       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.